Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter

Vitiligo patient-derived keratinocytes exhibit characteristics of normal wound healing via epithelial to mesenchymal transition

(2015) Poulomi Banerjee et al.   EXPERIMENTAL DERMATOLOGY

A Novel Dual AMPK Activator/mTOR Inhibitor Inhibits Thyroid Cancer Cell Growth

(2015) Robert L. Plews et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Dysregulation of Wnt-Signaling and a Candidate Set of miRNAs Underlie the Effect of Metformin on Neural Crest Cell Development

(2015) Poulomi Banerjee et al.   STEM CELLS

Metformin Suppresses Ovarian Cancer Growth and Metastasis with Enhancement of Cisplatin Cytotoxicity In Vivo

(2015) Ramandeep Rattan et al.   NEOPLASIA

Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition

(2013) Y.-C. Lin et al.   JOURNAL OF CELL SCIENCE

The Invasion Inhibitor Sarasinoside A1 Reverses Mesenchymal Tumor Transformation in an E-Cadherin–Independent Manner

(2013) Pamela Austin et al.   MOLECULAR CANCER RESEARCH

Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner

(2013) M. Cerezo et al.   MOLECULAR CANCER THERAPEUTICS

Repositioning metformin for cancer prevention and treatment

(2013) Brendan J. Quinn et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma

(2012) Qingqiong Luo et al.   BMC CANCER

G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer

(2012) Chenfang Dong et al.   JOURNAL OF CLINICAL INVESTIGATION

Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms

(2012) M E Law et al.   ONCOGENE

Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression

(2011) Hak-Su Kim et al.   BIOCHEMICAL PHARMACOLOGY

Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis

(2010) Sílvia Cufí et al.   CELL CYCLE

AMP-activated Protein Kinase Antagonizes Pro-apoptotic Extracellular Signal-regulated Kinase Activation by Inducing Dual-specificity Protein Phosphatases in Response to Glucose Deprivation in HCT116 Carcinoma

(2010) Min-Jung Kim et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

GATA3 Inhibits Breast Cancer Metastasis through the Reversal of Epithelial-Mesenchymal Transition

(2010) Wei Yan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Snail Family Regulation and Epithelial Mesenchymal Transitions in Breast Cancer Progression

(2010) Antonio Garcia de Herreros et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition

(2010) Yvonne L Chao et al.   Molecular Cancer

Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway

(2009) Shreyas Das et al.   BMC CELL BIOLOGY

New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes

(2009) G. Libby et al.   DIABETES CARE

E-Cadherin Upregulation as a Therapeutic Goal in Cancer Treatment

(2008) E. Howard et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Cadherins and cancer: how does cadherin dysfunction promote tumor progression?

(2008) A Jeanes et al.   ONCOGENE